LATAM Thyroid Eye Disease Market Size & Outlook, 2026-2034


LATAM Thyroid Eye Disease Market Insights

  • Reed Intelligence analysis indicates that the LATAM Thyroid Eye Disease Market size, which was USD 116.11 Million in 2025, is projected to attain USD 213.67 Million by 2034.
  • The market is expected to register a CAGR of 6.95% over the period 2026–2034.
  • In 2025, Biologics emerged as the dominant Therapy Type based on market size.
  • Biologics is projected to register the fastest growth, positioning it as the most attractive Therapy Type segment over the forecast horizon.

Other Key Findings


  • In 2025, LATAM accounted for 9.84% of the global Thyroid Eye Disease Market size.
  • By 2034, United States is projected to lead the global market in terms of market size.
  • Chile is projected to emerge as the fastest-growing market in LATAM, reaching USD 16.65 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 116.11 Million
Market Size In 2034 USD 213.67 Million
Largest segment Biologics
Units Revenue in USD Million
CAGR 6.95% (2026-2034)
Segmnetation Covered
LATAM
  1. Brazil
  2. Mexico
  3. Argentina
  4. Colombia
  5. Chile
Therapy Type
  1. Biologics
  2. Small Molecule Drugs
  3. Corticosteroids
Treatment Approach
  1. Pharmacological Therapy
  2. Combination Therapy
  3. Surgical Intervention
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports